FDA just approved the drug for asthma this week. PI- McQuaid Read Full Article Category: NewsBy PulmonixJune 28, 2018Post navigationPreviousPrevious post:New COPD Triple InhalerNextNext post:LeBauer HealthCare Selected for Prestigious Pulmonary Fibrosis NetworkRelated PostsPULMONIX VOLUNTEERS WITH THE KELLIN FOUNDATION TO SUPPORT FAMILIES IN NEEDJuly 18, 2025PULMONIX NAMED FINALIST FOR TRIAD BUSINESS JOURNAL’S BEST PLACES TO WORKMay 29, 2025PULMONIX CELEBRATES CLINICAL TRIALS DAY WITH DR. MARY JO CAGLEMay 20, 2025PULMONIX LEADERSHIP HONORED AT TRIAD BUSINESS JOURNAL C-SUITE AWARDSAugust 29, 2024
